Request for Information / Market Survey on NGS Analytics Software for Clinical Genetics Use
Tietopyyntö/ markkinakartoitus NGS-analytiikkaohjelmisto kliinisen genetiikan käyttöön
Finland · Oulu · how to bid here →
Your path to submission
- Deadline: 7 October at 09:00 — 3 days left.
- You submit on Hilma — not here and not by e-mail. ↗
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 3 months (4 awards, most recently June 2026) — by that rhythm the next award was due around September 2026. The last award went to CGI Suomi Oy.n = 4
- 38% of this buyer's awards went to companies that had already won here before (49 awards since 2023, spread over 27 companies). 62% went to new names.n = 49 awards since 2023
- The median procedure drew 2 bids (20 procedures with a bid count); 45% ended with a single bidder. Sector: median 2 bids.n = 20
- Not one of the 49 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 49
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Finland · Software & IT systems, 11 contracts went to foreign companies over the last 3 years (of 1,286 recorded awards).
Typical field: median 2 (from 686 awards).
What the buyer is looking for
NGS analytics software for clinical genetics NordLab is planning to acquire NGS analytics software for the area of responsibility of clinical laboratory genetics. The aim is to map out the solutions available on the market, their features and the ability of suppliers to meet current and future needs in clinical diagnostics. The purpose of the information request is to collect information to support the planning of the procurement. It is neither a contract notice nor a call for tenders, and the request for information does not oblige the contracting entity to carry out the procurement. The software is intended for clinical use in genetic research. The software should support the analysis and interpretation of NGS data and enable a high-quality, traceable and standard-compliant analysis process. The software will be used for the following purposes: The classification and clinical…
Show full description
… interpretation of variants NordLab is planning the procurement of NGS analytics software for use within its clinical laboratory genetics services. The objective is to gain insight into solutions available on the market, their capabilities, and suppliers' ability to meet current and future needs in clinical diagnostics. The purpose of this Request for Information (RFI) is to collect information to support procurement planning. This RFI is prohibited a contract notice nor a request for tender and does not obligate the contracting authority to carry out a procurement procedure. The software solution under consideration is intended for clinical use in genetic testing and analysis. The software should support NGS data analysis and interpretation and enable a high-quality, traceable, and standards-compliant analytical workflow. The software is expected to support, among others, the following use cases: Analysis of hereditary diseases Detection of somatic and germline variants Variant classification and clinical interpretation,
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Siemens Healthcare Oy | 4 | 2024–2026 |
| Biomerieux Suomi Oy | 3 | 2024–2026 |
| Roche diagnostics Oy | 3 | 2023–2025 |
| Chromsystems Instruments & Chemicals GmbH | 3 | 2025 |
| Suomen Punainen Risti, Veripalvelu | 3 | 2024–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.